Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, et al
Applicable Procedure Code: J1440
PlexusDx offers oral semaglutide as an alternative if needle-based therapy becomes emotionally or physically unbearable
Exenatide, lixisenatide, and semaglutide have an expiration date of 36 months, while liraglutide has an expiration date of 30 months
Yount, R
Other than saroglitazar, elafibranor, a PPAR / agonist, was tested in a 1-year phase II RCT involving 274 subjects with biopsy-proven NASH, 107 of whom were diabetic: using a modified post hoc primary endpoint, elafibranor resolved NASH in a significant percentage of patients, without worsening of fibrosis, and ameliorated the hepatic and metabolic profile [67]